Skip to main content

Peer Review reports

From: Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer

Original Submission
6 Jun 2018 Submitted Original manuscript
20 Oct 2018 Reviewed Reviewer Report - Hana Studentova
1 Nov 2018 Reviewed Reviewer Report - Melanie Royce
4 Nov 2018 Reviewed Reviewer Report - Shinichiro Kashiwagi
31 Jan 2019 Author responded Author comments - Edith A. Perez
Resubmission - Version 2
31 Jan 2019 Submitted Manuscript version 2
14 Feb 2019 Reviewed Reviewer Report - Shinichiro Kashiwagi
27 Feb 2019 Reviewed Reviewer Report - Melanie Royce
25 Mar 2019 Author responded Author comments - Edith A. Perez
Resubmission - Version 3
25 Mar 2019 Submitted Manuscript version 3
1 May 2019 Author responded Author comments - Edith A. Perez
Resubmission - Version 4
1 May 2019 Submitted Manuscript version 4
Publishing
8 May 2019 Editorially accepted
30 May 2019 Article published 10.1186/s12885-019-5687-0

You can find further information about peer review here.

Back to article page